☰

Empresas y finanzas

Medidata Solutions Introduces New eLearning Tool in Rave 5.6.2


    Medidata Solutions, a global provider of electronic clinical data
    capture, management and reporting solutions, today announced the
    introduction of Medidata Rave 5.6.2. With this version, Medidata has
    incorporated its eLearning module directly into the Rave system,
    allowing sponsors to empower investigator sites to quickly and easily
    become trained on Rave, speeding study start-up and patient data
    gathering. In addition to its eLearning capabilities, Medidata Rave
    5.6.2 comes with a range of tools that offer sponsors new ways to
    increase productivity and enhance the research experience for the
    clinical study team.

    Since its inception, Medidata Rave was designed for maximum ease
    of use and, as a result, training for users at sites and sponsors has
    remained quick and simple. By incorporating Medidata´s existing
    eLearning capabilities into the Rave system, Medidata now provides
    rapid and targeted user training directly within the familiar Rave
    interface. With instant access 24/7 worldwide on any Web-enabled
    computer, sites and sponsors benefit from the following eLearning
    features:

    Sites

    -- Customized, on-demand and self-paced training courses for ease
    of use;

    -- Immediate and seamless access to the study once automated
    training is completed, enabling faster trial start and data
    collection;

    -- Instant, downloadable and printable certification available to
    investigators and sponsors.

    Sponsors

    -- Secure log-in to eLearning without additional administrative
    steps;

    -- Easy and fast deployment and delivery of training for all Rave
    users;

    -- Web-based, simple training for time, task and cost savings.

    "As Medidata Rave continues to play an increasingly important role
    in our clinical trial functions, it has been critical for us to
    establish an efficient training program, especially with some of our
    largest studies where we have to bring multiple investigators and
    sites up to speed," said Louise Archer, Data Management Technology
    Process Manager at AstraZeneca. "Medidata Rave´s enhanced eLearning
    tool will provide us with customizable, easy and fast training and
    user education directly within the Medidata Rave system, ultimately
    leading to better trained investigators, faster study starts and
    higher cost savings."

    Beyond eLearning: Rave 5.6.2 New Features and Enhancements

    In addition to its eLearning functionality, Medidata Rave 5.6.2
    provides further productivity and efficiency for the clinical study
    team through enhancements and additions to the industry-leading Rave
    5.6 platform. The experience of users - from site personnel and
    monitors to managers and data administrators as well as study builders
    at sponsors who build their own trials - has been upgraded with:

    -- Configurable Welcome Message: Allowing study managers to
    display appropriate customized messages which can be targeted
    to a specific study and/or role and translated into multiple
    languages on the home page;

    -- Publish-in-Place: Speeding the study build process by allowing
    immediate updating of CRF versions during development;

    -- Custom Function Development Utility: Assisting study builders
    in development and testing of custom edit checks building
    complex data queries;

    -- User Loader: Allowing user administrators to speed the
    enrollment and maintenance of user information by uploading or
    downloading files;

    -- Performance Enhancements: Providing improved page refresh
    performance and a host of other system enhancements that
    significantly upgrades system speed for all users.

    "Our customers - global pharmaceutical and medical device
    companies, biotechs, CROs and academic and government institutions -
    continue to rely on Medidata Rave as the central tool for their global
    clinical trial information collection, management and reporting," said
    Glen de Vries, CTO of Medidata Solutions. "In version 5.6.2, we
    designed a host of enhancements and additions that will significantly
    benefit all the functions in the clinical trial process - from
    investigators and coordinators at the site level to data managers and
    user administrators to study builders."

    About Medidata Solutions Worldwide

    Medidata Solutions helps the world´s leading pharmaceutical,
    biotechnology, medical device and research organizations maximize the
    value of their clinical research investments. Innovative process
    design, technology and services streamline clinical trials by
    providing early visibility to reliable clinical data - the lifeblood
    of every research organization. Working with companies and
    institutions both large and small, Medidata Solutions helps clinical
    researchers safely accelerate the process of bringing life-enhancing
    treatments to market - on six continents and in more than 80
    countries. Medidata Solutions brings significant value to its broad
    client base with deep clinical experience and expertise in more than
    20 therapeutic areas, projects in Phase I, II, III, IV, registries and
    surveillance, and studies with thousands of investigators and
    tens-of-thousands of subjects. For more information, please visit
    www.mdsol.com.